Astrazeneca Pharma India's Stock Sees Decline Amid Mixed Moving Averages

Astrazeneca Pharma India, a midcap pharmaceutical company, has been in the news recently due to its stock performance. On November 14, 2024, the company's stock saw a decline of -5.8%, underperforming the sector by -5.78%. This has led to a 'Hold' call by MarketsMOJO for the stock.

The stock has been on a consecutive fall for the last 2 days, with a total decline of -8.22% during this period. On the same day, the stock touched an intraday low of Rs 6770, marking a -5.8% decrease.

In terms of moving averages, the stock is currently higher than its 200 day moving average, but lower than its 5 day, 20 day, 50 day, and 100 day moving averages. This indicates a mixed trend for the stock.

In comparison to the overall market performance, Astrazeneca Pharma India's stock has seen a -5.14% decline in the last 1 day, while the Sensex has seen a 0.43% increase. Over the last 1 month, the stock has seen a -11.02% decline, while the Sensex has seen a -4.81% decline.

It is important to note that this article is based on factual information and does not include any external data or sources. It is not intended to provide any recommendations or discuss potential future performance. As a midcap pharmaceutical company, Astrazeneca Pharma India's stock performance will continue to be closely watched by investors and analysts in the coming days.